Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Oct 5;17(11):78.
doi: 10.1007/s11882-017-0749-3.

Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID)

Affiliations
Review

Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID)

Jan F Mieves et al. Curr Allergy Asthma Rep. .

Abstract

Purpose of review: Vaccination against influenza in patients with primary antibody deficiency is recommended. Common variable immunodeficiency (CVID) is the most frequent and clinically relevant antibody deficiency disease and is by definition characterized by an impaired vaccination response. The purpose of this review is to present the current knowledge of humoral and cellular vaccine response to influenza in CVID patients.

Recent findings: Studies conducted in CVID patients demonstrated an impaired humoral response upon influenza vaccination. Data on cellular immune response are in part conflicting, with two out of three studies showing responses similar to healthy controls. Available data suggest a benefit from influenza vaccination in CVID patients. Therefore, annual influenza vaccination in patients and their close household contacts is recommended.

Keywords: Common variable immunodeficiency; Influenza; Primary antibody deficiency; Vaccination.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Med Virol. 2000 May;61(1):94-9 - PubMed
    1. J Clin Immunol. 2015 Feb;35(2):213-7 - PubMed
    1. Front Immunol. 2016 Jun 13;7:220 - PubMed
    1. Vaccine. 2016 Oct 26;34(45):5442-5448 - PubMed
    1. Nat Rev Immunol. 2008 Apr;8(4):247-58 - PubMed

Substances

LinkOut - more resources